Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
33.10
+0.15 (0.46%)
Jan 21, 2026, 1:14 PM EST - Market open
Indivior Market Cap
Indivior has a market cap or net worth of $4.13 billion as of January 21, 2026. Its market cap has increased by 164.69% in one year.
Market Cap
4.13B
Enterprise Value
3.99B
1-Year Change
164.69%
Ranking
Category
Stock Price
$33.10
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $4.13B, an increase of 170.01%. That is a compound annual growth rate of 9.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 4.11B | -8.17% |
| Dec 31, 2025 | 4.48B | 188.39% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hims & Hers Health | 6.94B |
| Alkermes | 5.24B |
| Lantheus Holdings | 4.37B |
| Amneal Pharmaceuticals | 4.19B |
| Prestige Consumer Healthcare | 3.11B |
| Kiniksa Pharmaceuticals International, | 3.11B |
| Supernus Pharmaceuticals | 2.86B |
| HUTCHMED (China) | 2.60B |